I don’t think endorsing the product as they have done is any risk to their career. Based on what I know so far we have very good product and if I was an expert in this area may be I would have endorsed it as well ( btw I am NOT so it's just a hypothetical "IF").
However, the issue here seems to be whether this company in its current form would be able to monetise/capitalise on products to the benefit of the existing shareholders and hence there is an investment risk. I believe this risk in investment is why the experts and in particular our CEO is reluctant to invest. However, this is just me speculating and would love to know the reason why CEO in particular is reluctant to buy share in this company and hence my question.
@platinumstandard do you see any problem for me trying to understand why the CEO has not invested in this company?
I don’t think endorsing the product as they have done is any...
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.00 |
Change
-0.350(2.02%) |
Mkt cap ! $327.3M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $150.7K | 8.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 388 | $17.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.13 | 35 | 2 |
View Market Depth
| Last trade - 11.26am 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |